Sign in
Estimated Cost-effectiveness of Subcutaneous Insulin Aspart in the Management of Mild Diabetic Ketoacidosis Among Children
Journal article   Open access  Peer reviewed

Estimated Cost-effectiveness of Subcutaneous Insulin Aspart in the Management of Mild Diabetic Ketoacidosis Among Children

JAMA network open, Vol.5(9), pp.e2230043-e2230043
06/09/2022
PMID: 36066894

Abstract

Online Only Original Investigation Pediatrics
This economic evaluation compares the cost-effectiveness associated with the use of subcutaneous insulin aspart vs intravenous insulin infusion for management of mild diabetic ketoacidosis in children.
url
https://doi.org/10.1001/jamanetworkopen.2022.30043View
Published (Version of record) Open

Details